SKIP TO
CONTENT
Philips Recalled CPAP, Bi-Level PAP, and Mechanical...
featured news
November 28, 2013
False Claims Act Legal News
The Effect of the Affordable Care Act Upon the Federal Anti-Kickback Statute
According to the Department of Health and Human Services, the federal anti-kickback statute serves one purpose: to protect patients and the federal health care programs from fraud and abuse by curtailing the corrupting influence of money on health care decisions. As we have reported in the past, this law has proven […]
November 15, 2013
False Claims Act Legal News
Renowned Software Company to Pay $11 million in Penalties Under the False Claims Act
We often report about violations of the False Claims Act as pertaining to healthcare billing fraud. However, fraud against the government can appear pursuant to nearly any contract, and today’s article explores a recent settlement involving software billing fraud. Under the FCA, companies holding contracts paid for by taxpayer dollars […]
November 1, 2013
False Claims Act Legal News
Berger Montague Announces Nationwide Series of Suits on Omnicare’s ‘Swapping’ Scheme–Pt 2
In yesterday’s post, we discussed the details of the case we are working on against Omnicare, Inc. and various other pharmacy service companies. We provided an in-depth look into Medicare Part A and D benefits and how Omnicare was profiting from kickbacks offered to nursing homes desperate to provide cost-effective […]
October 22, 2013
Healthcare Fraud
Pacemaker Manufacturer Settles False Claims Act Case for $30 Million
Any individual with original information about fraudulent Medicaid or Medicare claims may come forward as a whistleblower under the federal False Claims Act (“FCA”). Under the FCA, it is considered against the law for a doctor to offer or implant a medical device that is known to be faulty and […]
October 18, 2013
Healthcare Fraud
Case Against C.R. Bard Intensifies as Judge to Consider Whistleblower’s New Complaint
The False Claims Act bars, among other things, unlawful kickbacks to physicians pertaining to any patient interaction to be subsequently billed to Medicare or Medicaid. The FCA also prohibits drug manufacturers from marketing or selling products in ways other than those approved by the FDA. Any deviation from the approved […]
schedule a free consultation
"*" indicates required fields
By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.
$50B+
in Settlements & Verdicts
53+
Years of High-Profile Cases
100+
Attorneys Protecting Your Rights
2X
Named “Trial Lawyer of the Year”
50
States in Which The Firm Has Successfully Litigated Cases
On the Cutting Edge of the Profession
Legal Intelligencer
53
Years
